Bionano Genomics (BNGO) Operating Margin (2017 - 2026)
Bionano Genomics' (BNGO) quarterly Operating Margin came in at 118.09% in Q1 2026, up 1300.0% year-on-year from 8.44% in Q1 2025, and down 10.0% quarter-over-quarter from 107.36% in Q4 2025.
Bionano Genomics (BNGO) Operating Margin (2017 - 2026) Analysis & Trends
Bionano Genomics has disclosed Operating Margin across 10 years of filings, most recently posting 118.09% for Q1 2026.
- Operating Margin for Q1 2026 came in at 118.09%, up 1300.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 114.03% (down 11102.0% YoY), and the FY2025 annual result was 116.95%, down 4053.0% from the prior year.
- Operating Margin came in at 118.09% for Q1 2026 at Bionano Genomics, down from 107.36% in the prior quarter.
- In the past five years, Operating Margin ranged from a high of 839.46% in Q4 2024 to a low of 1214.98% in Q3 2023.
- The 5-year median for Operating Margin is 354.92% (2024), against an average of 315.61%.
- Across the five-year window, Operating Margin surged 107221 bps in 2024 and slumped 94682 bps in 2025, its largest moves.
- Bionano Genomics' Operating Margin stood at 456.81% in 2022, then surged by 49 bps to 232.75% in 2023, then jumped by 461 bps to 839.46% in 2024, then sank by 113 bps to 107.36% in 2025, then dropped by 10 bps to 118.09% in 2026.
- The last three Operating Margin figures came in at 118.09% (Q1 2026), 107.36% (Q4 2025), and 115.9% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 30.87% |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | 1.97% |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | 5.74% |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 34.92% |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 20.96% |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | 4.04% |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | -2.87% |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 13.65% |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 2.44% |
| 10 | Bionano Genomics | 14.01 Mn | -366,620.40 | 3.25 Mn | -118.09% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -118.09% |
| Dec 31, 2025 | -107.36% |
| Sep 30, 2025 | -115.90% |
| Jun 30, 2025 | -115.85% |
| Mar 31, 2025 | -131.10% |
| Dec 31, 2024 | 839.46% |
| Sep 30, 2024 | -722.89% |
| Jun 30, 2024 | -218.99% |
| Mar 31, 2024 | -354.92% |
| Dec 31, 2023 | -232.75% |
| Sep 30, 2023 | -1,214.98% |
| Jun 30, 2023 | -452.99% |
| Mar 31, 2023 | -510.36% |
| Dec 31, 2022 | -456.81% |
| Sep 30, 2022 | -445.22% |
| Jun 30, 2022 | -480.94% |
| Mar 31, 2022 | -525.68% |
| Dec 31, 2021 | -456.73% |
| Sep 30, 2021 | -444.21% |
| Jun 30, 2021 | -427.28% |